Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R DOWNING

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significanceJ E Rubnitz, J R Downing, C H Pui, et al.
Clinical Pharmacology and Therapeutics|June 18, 2016
Comparison of genome sequencing and clinical genotyping for pharmacogenesW Yang, G Wu, U Broeckel, et al.
Leukemia|December 17, 2009
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui, D Pei, J T Sandlund, et al.
Leukemia|June 8, 2011
IDH1 and IDH2 mutations in pediatric acute leukemiaA K Andersson, D W Miller, J A Lynch, et al.
Oncogene|May 10, 2011
Shared acquired genomic changes in zebrafish and human T-ALLL A Rudner, K H Brown, K P Dobrinski, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
Leukemia|May 1, 2014
A revised definition for cure of childhood acute lymphoblastic leukemiaC H Pui, D Pei, D Campana, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significanceJ E Rubnitz, J R Downing, C H Pui, et al.
Clinical Pharmacology and Therapeutics|June 18, 2016
Comparison of genome sequencing and clinical genotyping for pharmacogenesW Yang, G Wu, U Broeckel, et al.
Leukemia|December 17, 2009
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui, D Pei, J T Sandlund, et al.
Leukemia|June 8, 2011
IDH1 and IDH2 mutations in pediatric acute leukemiaA K Andersson, D W Miller, J A Lynch, et al.
Oncogene|May 10, 2011
Shared acquired genomic changes in zebrafish and human T-ALLL A Rudner, K H Brown, K P Dobrinski, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
Leukemia|May 1, 2014
A revised definition for cure of childhood acute lymphoblastic leukemiaC H Pui, D Pei, D Campana, et al.
Pageof 12